Headline News Archive
Click on title to read the full article.
HER2-Targeted Therapies: How Far We've Come—and Where We’re Headed
April 24, 2020
By Nancy E. Davidson, MD
In 2004, Dr. Leisha Emens and I reviewed the use of trastuzumab(Drug information on trastuzumab) (Herceptin), the monoclonal antibody directed against the HER2 protein, in the treatment of breast cancer. At that time, trastuzumab as monotherapy or in combination with chemotherapy was established as a standard of care for women with advanced HER2-overexpressing metastatic breast cancer. Much new information has emerged in the ensuing seven years.
NYU Langone Medical Center awarded $4.5 million for breast cancer research
April 20, 2020
NYU Langone Medical Center announced today the U.S. Department of Defense (DOD) Breast Cancer Research Program (BCRP) of the Office of the Congressionally Directed Medical Research Programs has awarded Silvia Formenti, MD, the Sandra and Edward Meyer Professor and Chair of the Department of Radiation Oncology a $4.5 million Multi-Team Award to conduct novel breast cancer research.
UAB launches drug trial aimed at triple-negative breast cancers
April 12, 2020
By Nicole Wyatt
A drug to treat metastatic, triple-negative breast cancer is being tested in a national clinical trial at the UAB Comprehensive Cancer Center, where it was developed.
Roche announces positive Phase II results for trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer
April 8, 2020
By ChemInfoNews
Roche today announced topline results of its first randomized trial of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer.
Molecules identified that help propel cancer metastasis
April 8, 2020
By Kim Newman
For many types of cancer, the original tumor itself is usually not deadly. Instead, it's the spread of a tiny subpopulation of cells from the primary tumor to other parts of the body—the process known as metastasis—that all too often kills the patient. Now, researchers at Albert Einstein College of Medicine of Yeshiva University have identified two molecules that enable cancer to spread inside the body. These findings could eventually lead to therapies that prevent metastasis by inactivating the molecules.
DNA of 50 breast cancer patients decoded
April 4, 2020
By Julia Evangelou Strait
In the single largest cancer genomics investigation reported to date, scientists have sequenced the whole genomes of tumors from 50 breast cancer patients and compared them to the matched DNA of the same patients’ healthy cells.
Headline News Archive
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- October 2007
- September 2007